Combined Cellular Automaton Model for Dynamic Recrystallization Evolution of 42CrMo Cast Steel

by Yi-Na Guo, Yong-Tang Li, Wen-Yan Tian, Hui-Ping Qi, Hong-Hong Yan
Published 2018-10-01

Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study

by Jia-Tao Zhang, Si-Yang Liu, Hong-Hong Yan, Yi-Long Wu, Qiang Nie, Wen-Zhao Zhong
Published 2019-11-01

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma

by Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng, Xue-Kui Liu
Published 2016-10-01

Three‐dimensional printed navigational template for localizing small pulmonary nodules: A case‐controlled study

by Rui Fu, Yun‐Fei Chai, Jia‐Tao Zhang, Tao Zhang, Xiao‐Kun Chen, Song Dong, Hong‐Hong Yan, Xue‐Ning Yang, Mei‐Ping Huang, Yi‐Long Wu, Jian Zhuang, Wen‐Zhao Zhong
Published 2020-09-01

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

by Qing Zhou, Jin-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang, Hong-Hong Yan, Chong-Rui Xu, Jian Su, Hua-Jun Chen, Hai-Yan Tu, Wen-Zhao Zhong, Xue-Ning Yang, Yi-Long Wu
Published 2016-09-01

Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort stud

by Yi-Long Wu, De-Hua Wu, Si-Cong Ma, Xin-Ran Tang, Shuai Kang, Qiang John Fu, Chuan-Hui Cao, He-San Luo, Yu-Han Chen, Hong-Bo Zhu, Hong-Hong Yan, Zhong-Yi Dong
Published 2020-06-01

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.

by She-Juan An, Zhi-Hong Chen, Jian Su, Xu-Chao Zhang, Wen-Zhao Zhong, Jin-Ji Yang, Qing Zhou, Xue-Ning Yang, Ling Huang, Ji-Lin Guan, Qiang Nie, Hong-Hong Yan, Tony S Mok, Yi-Long Wu
Published 2012-01-01

Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism

by Si‐Yang Liu, Jia‐Ying Zhou, Wen‐Feng Li, Hao Sun, Yi‐Chen Zhang, Hong‐Hong Yan, Zhi‐Hong Chen, Chun‐Xiang Chen, Jun‐Yi Ye, Jin‐Ji Yang, Qing Zhou, Xu‐Chao Zhang, Yi‐Long Wu
Published 2020-03-01

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

by Rui-Lian Chen, Jun Zhao, Xu-Chao Zhang, Na-Na Lou, Hua-Jun Chen, Xue Yang, Jian Su, Zhi Xie, Qing Zhou, Hai-Yan Tu, Wen-Zhao Zhong, Hong-Hong Yan, Wei-Bang Guo, Yi-Long Wu, Jin-Ji Yang
Published 2018-11-01

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

by Hao Sun, Si-Yang Liu, Jia-Ying Zhou, Jin-Tian Xu, Huang-Kai Zhang, Hong-Hong Yan, Jiao-Jiao Huan, Ping-Ping Dai, Chong-Rui Xu, Jian Su, Yan-Fang Guan, Xin Yi, Rong-Shan Yu, Wen-Zhao Zhong, Yi-Long Wu
Published 2020-10-01

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

by Jing‐Hua Chen, Xiang‐Peng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hong‐Ping Zheng, Ze‐Xin Chen, Xin Chen, Meng‐Meng Song, Xin Yi, Pan‐Song Li, Yan‐Fang Guan, Gang Li, Chu‐Xia Deng, Rafael Rosell, Yi‐Long Wu, Wen‐Zhao Zhong
Published 2020-08-01

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I...

by Yi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, Chong-Rui Xu, Hong-Hong Yan, Zhi Xie, Shao-Kun Chuai, Jun-Yi Ye, Han Han-Zhang, Zhou Zhang, Xiao-Yan Bai, Jian Su, Bin Gan, Jin-Ji Yang, Wen-Feng Li, Wei Tang, Feng Roger Luo, Xiao Xu, Yi-Long Wu, Qing Zhou
Published 2019-05-01